ACM Research CEO David H. Wang sells 130K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ACM Research, Inc. (ACMR) CEO, President, Director and ten-percent owner David H. Wang exercised stock options covering 65,000 Class A shares at a $1 exercise price on each of November 17 and 18, 2026, acquiring 65,000 shares each day. He sold 130,000 Class A shares across those dates; reported sale prices were weighted averages for multiple transactions. The sales were made under a Rule 10b5-1 trading plan adopted June 5, 2026.
The report separately lists indirect Class A holdings dated November 17, 2026: 100,002 shares held by his wife, Jing Chen; 180,000 by the David Hui Wang and Jing Chen Family Irrevocable Trust for Wang Children; and 620,001 by the Wang-Chen Family Living Trust.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option F8 | 65,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 65,000 | $1.00 | $65K |
| Sale | Class A Common Stock F1, F6 | 51,475 | $43.28 | $2.23M |
| Sale | Class A Common Stock F1, F7 | 13,525 | $44.12 | $597K |
| Exercise | Stock Option F8 | 65,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 65,000 | $1.00 | $65K |
| Sale | Class A Common Stock F1, F2 | 19,327 | $42.71 | $825K |
| Sale | Class A Common Stock F1, F3 | 26,762 | $43.32 | $1.16M |
| Sale | Class A Common Stock F1, F4 | 18,511 | $44.43 | $822K |
| Sale | Class A Common Stock F1, F5 | 400 | $45.02 | $18K |
| Holding | Class A Common Stock | -- | -- | -- |
| Holding | Class A Common Stock | -- | -- | -- |
| Holding | Class A Common Stock | -- | -- | -- |
Footnotes (8)
- F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2026.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), (6), and (7) to this Form 4.
- F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.99, inclusive.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.00 to $44.82, inclusive.
- F5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.02 to $45.02, inclusive.
- F6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.81 to $43.80, inclusive.
- F7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.82 to $44.67, inclusive.
- F8. The option is fully vested and exercisable.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
fully vested and exercisable financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ACMR options did David H. Wang exercise, and at what price?
AI-generated analysis. How Rhea-AI works. Not financial advice.